Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Dejaco

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Rheumatology|September 19, 2008
Diagnostic values of history and clinical examination to predict ultrasound signs of chronic and acute enthesitisA S Klauser, E Wipfler, C Dejaco, et al.
Rheumatology (Oxford, England)|September 15, 2005
High positive predictive value of specific antibodies cross-reacting with a 28-kDa Drosophila antigen for diagnosis of ankylosing spondylitisC Duftner, C Dejaco, A Klauser, et al.
Hepato-Gastroenterology|November 1, 1996
Detection of Helicobacter pylori infection using single serum specimens: comparison of five commercial serological testsF Allerberger, G Oberhuber, F Wrba, et al.
Clinical and Experimental Rheumatology|September 24, 2009
Urate oxidase (rasburicase) for treatment of severe acute gout: a case reportE Wipfler-Freibmuth, C Dejaco, C Duftner, et al.
Journal of Hepatology|July 29, 1999
Stenosis of the common bile duct due to Ormond's disease: case report and review of the literatureC Dejaco, P Ferenci, E Schober, et al.
Alimentary Pharmacology & Therapeutics|June 6, 2003
An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgiaW Reinisch, W Miehsler, C Dejaco, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 30, 2000
In vivo effects of recombinant human interleukin-10 on lymphocyte phenotypes and leukocyte activation markers in inflammatory bowel diseaseC Dejaco, W Reinisch, C Lichtenberger, et al.
Scandinavian Journal of Rheumatology|January 15, 2011
Similar performance of DAS-28, CDAI, and SDAI in rheumatoid arthritis patients with and without sonographic signs of active inflammation in routine clinical practiceC Dejaco, C Duftner, E Wipfler-Freissmuth, et al.
Annals of the Rheumatic Diseases|October 13, 2005
Preferential type 1 chemokine receptors and cytokine production of CD28- T cells in ankylosing spondylitisC Duftner, C Dejaco, W Kullich, et al.
Zeitschrift Fur Gastroenterologie|February 4, 2014
[Adalimumab for the treatment of ulcerative colitis--a consensus report by the working group inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology]G Novacek, C Dejaco, P Knoflach, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Rheumatology|September 19, 2008
Diagnostic values of history and clinical examination to predict ultrasound signs of chronic and acute enthesitisA S Klauser, E Wipfler, C Dejaco, et al.
Rheumatology (Oxford, England)|September 15, 2005
High positive predictive value of specific antibodies cross-reacting with a 28-kDa Drosophila antigen for diagnosis of ankylosing spondylitisC Duftner, C Dejaco, A Klauser, et al.
Hepato-Gastroenterology|November 1, 1996
Detection of Helicobacter pylori infection using single serum specimens: comparison of five commercial serological testsF Allerberger, G Oberhuber, F Wrba, et al.
Clinical and Experimental Rheumatology|September 24, 2009
Urate oxidase (rasburicase) for treatment of severe acute gout: a case reportE Wipfler-Freibmuth, C Dejaco, C Duftner, et al.
Journal of Hepatology|July 29, 1999
Stenosis of the common bile duct due to Ormond's disease: case report and review of the literatureC Dejaco, P Ferenci, E Schober, et al.
Alimentary Pharmacology & Therapeutics|June 6, 2003
An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgiaW Reinisch, W Miehsler, C Dejaco, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 30, 2000
In vivo effects of recombinant human interleukin-10 on lymphocyte phenotypes and leukocyte activation markers in inflammatory bowel diseaseC Dejaco, W Reinisch, C Lichtenberger, et al.
Scandinavian Journal of Rheumatology|January 15, 2011
Similar performance of DAS-28, CDAI, and SDAI in rheumatoid arthritis patients with and without sonographic signs of active inflammation in routine clinical practiceC Dejaco, C Duftner, E Wipfler-Freissmuth, et al.
Annals of the Rheumatic Diseases|October 13, 2005
Preferential type 1 chemokine receptors and cytokine production of CD28- T cells in ankylosing spondylitisC Duftner, C Dejaco, W Kullich, et al.
Zeitschrift Fur Gastroenterologie|February 4, 2014
[Adalimumab for the treatment of ulcerative colitis--a consensus report by the working group inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology]G Novacek, C Dejaco, P Knoflach, et al.
Pageof 7